financetom
Business
financetom
/
Business
/
Merck's HIV treatment meets main goal of two late-stage studies
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Merck's HIV treatment meets main goal of two late-stage studies
Dec 19, 2024 4:12 AM

Dec 19 (Reuters) - Merck ( MRK ) said on Thursday its

experimental drug combination to treat some adults with HIV-1

infection met the main goal of two late-stage studies.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Aveanna Healthcare Holdings Insider Sold Shares Worth $571,211, According to a Recent SEC Filing
Aveanna Healthcare Holdings Insider Sold Shares Worth $571,211, According to a Recent SEC Filing
May 26, 2025
11:28 AM EDT, 05/12/2025 (MT Newswires) -- Robert M Williams Jr, 10% Owner, on May 08, 2025, sold 98,037 shares in Aveanna Healthcare Holdings ( AVAH ) for $571,211. Following the Form 4 filing with the SEC, Williams has control over a total of 54,162,448 common shares of the company, with 54,162,448 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1832332/000095017025068770/xslF345X05/ownership.xml Price: 5.48, Change:...
Bloomin' Brands Invests For Longer-Term Growth, Will Do 'Fewer Things Better'
Bloomin' Brands Invests For Longer-Term Growth, Will Do 'Fewer Things Better'
May 26, 2025
Shares of Bloomin’ Brands Inc.  climbed in early Monday trading despite the company reporting a decline in first-quarter sales on Friday. CEO Mike Spanos is identifying various investments that are necessary for the longer-term vitality of the company's different businesses, according to JPMorgan.  The Bloomin’ Brands Analyst: Analyst John Ivankoe maintained a Neutral rating and price target of $9. The Bloomin’...
NRG Energy Surges As Q1 Crushes Forecasts, LS Power Deal Supercharges Long-Term Outlook
NRG Energy Surges As Q1 Crushes Forecasts, LS Power Deal Supercharges Long-Term Outlook
May 26, 2025
NRG Energy, Inc.’s stock skyrocketed after the company reported better-than-expected first-quarter 2025 results and announced the acquisition of Premier Power Portfolio from LS Power. NRG reported a revenue increase of 15.6% year-over-year to $8.59 billion, beating the consensus of $7.83 billion. Adjusted EPS stood at $2.62, beating the consensus of $1.49. Quarterly operating income rose 30.9% YoY to $1.134 billion,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved